T. Müller

发表

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.

T. Welte, L. Edler, M. Kneba, 2002, European journal of cancer.

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.

K. Dalhoff, L. Edler, T. Walter, 2001, European journal of cancer.

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

R. Greil, S. Kubicka, E. Van Cutsem, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

New Therapy Options for Neuroendocrine Carcinoma of the Pancreas—The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo

W. Uhl, P. Höhn, M. Buchholz, 2022, Cancers.

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

M. Lux, M. Beckmann, P. Fasching, 2014, BMC Cancer.

Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma—A 3-D In Vitro Study

W. Uhl, P. Höhn, M. Buchholz, 2022, International journal of molecular sciences.

Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1‐integrin‐dependent mechanism

C. Müller-Tidow, C. Wickenhauser, R. Benndorf, 2016, International journal of cancer.

Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines.

A. Grothey, W. Voigt, C. Hoang‐Vu, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus

W. März, C. Wanner, S. Störk, 2022, Clinical kidney journal.

Primary tumor location as a prognostic factor in metastatic colorectal cancer.

H. Lenz, H. Hurwitz, L. Saltz, 2015, Journal of the National Cancer Institute.

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

A. Rossi, C. Gridelli, A. Favaretto, 2005 .

The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors

A. Grothey, W. Dempke, W. Voigt, 1999, Journal of Cancer Research and Clinical Oncology.

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.

M. Volm, E. W. Hahn, J. Mattern, 1988, Cancer research.

A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).

C. Bokemeyer, W. Engel-Riedel, C. Kortsik, 2007, Lung cancer.

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

M. Ratain, C. Ng, R. Salgia, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.

C. Eschbach, F. Schneller, S. Guetz, 2013, Clinical lung cancer.

An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results

J. Becker, T. Gambichler, E. Stockfleth, 2023, Dermato.

Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study.

M. Volm, J. Mattern, T. Müller, 1988, Anticancer research.

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients With Advanced/Metastatic Solid Tumors or Lymphomas.

F. Hodi, F. Meric-Bernstam, W. Messersmith, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

M. Lux, M. Beckmann, P. Fasching, 2014, BMC Cancer.

Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study.

R. Dummer, F. Meric-Bernstam, G. Long, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.

T. Welte, W. Engel-Riedel, C. Kortsik, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer

E. Jaffee, D. Le, Shih-Yu Chen, 2020, Cancer Immunology Research.

Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

G. Shapiro, P. LoRusso, S. Swann, 2013, Investigational New Drugs.

A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

G. Shapiro, P. LoRusso, S. Swann, 2012, Investigational New Drugs.

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

A. Rossi, C. Gridelli, A. Favaretto, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MRTF-A controls myofibroblastic differentiation of human multipotent stromal cells and their tumour-supporting function in xenograft models

G. Posern, L. Müller, T. Müller, 2019, Scientific Reports.

SINGLE-CELL IMMUNE COMPETENCY SIGNATURES ASSOCIATE WITH SURVIVAL IN PHASE 2 GVAX AND CRS-207 RANDOMIZED STUDIES IN METASTATIC PANCREATIC CANCER PATIENTS

E. Jaffee, D. Le, Shih-Yu Chen, 2020 .

The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results.

J. Becker, T. Gambichler, M. Buchholz, 2023, Journal of cancer research and clinical oncology.

Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.

W. Dempke, W. Voigt, S. Eisenmann, 2010, Anticancer research.

R. Greil, S. Kubicka, M. Makrutzki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.